Ravi Prakash Arya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ravi Prakash Arya has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Vidya Avinash Arankalle
Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed To Be University), Pune, India
5 shared publications Anismrita Lahon
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America
3 shared publications- Rebecca Rico-Hesse
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America
3 shared publications Alexander R Kneubehl
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America
2 shared publications- Anismrita Lahon
Department of Viral Vaccines, Institute of Advanced Virology, Bio 360 Life Science Park, Thiruvananthapuram, Kerala, India
2 shared publications Ashwini Y. Ramdasi
Hepatitis Division, National Institute of Virology, Pashan, Pune, Maharashtra, India
2 shared publications
Latest Publications
- Open Access
- 25 July 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (1)
Elucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation
Replication is started by DNA primase, which synthesizes an oligoribonucleotide primer that DNA polymerases extend. Effective chemotherapy is still needed to manage and treat leishmaniasis, which continues to pose a threat to public health around the world. Repurposing drugs offers alternative uses for drugs with established pharmacological effects, saving money and increasing the pool of human resources available to create novel anti‐leishmanials. Here, we used a non‐radioactive primase‐pyrophosphatase assay to biochemically characterize the Leishmania donovani nuclear DNA primase ( LdPri ) subunits, followed by in silico evaluation of inhibitors targeting LdPri . The best‐evaluated inhibitors showed LdPri inhibition in vitro under conditions similar to those of the primase‐pyrophosphatase experiment. The MTT assay also confirmed the inhibitors' anti‐leishmanial properties. Parasite growth and morphological analysis were performed by culturing cells in the presence of inhibitors. Biochemical characterization revealed that LdPriS activity was unstable, but was highly stabilized upon association with LdPriL in LdPri . LdPri was found to be thermostable and possesses 3′‐terminal nucleotidyltransferase activity. Additionally, in silico and in vitro studies evaluated Pritelivir (BAY 57‐1293) as the most efficient LdPri complex inhibitor, followed by Epigallocatechin Gallate (EGCG). Moreover, kinetic studies showed that Pritelivir and EGCG exhibit competitive and uncompetitive inhibition, respectively, for both NTP and DNA substrates. Pritelivir effectively disrupted the L. donovani cell cycle, and the replication mechanism in treated promastigotes showed irregular shapes and short flagella.
- 25 July 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (1)
Open AccessElucidation of DNA Primase as a Drug Target in Leishmania donovani : Structure‐Guided Inhibitor Identification and Biochemical Validation
Replication is started by DNA primase, which synthesizes an oligoribonucleotide primer that DNA polymerases extend. Effective chemotherapy is still needed to manage and treat leishmaniasis, which continues to pose a threat to public health around the world. Repurposing drugs offers alternative uses for drugs with established pharmacological effects, saving money and increasing the pool of human resources available to create novel anti‐leishmanials. Here, we used a non‐radioactive primase‐pyrophosphatase assay to biochemically characterize the Leishmania donovani nuclear DNA primase ( LdPri ) subunits, followed by in silico evaluation of inhibitors targeting LdPri . The best‐evaluated inhibitors showed LdPri inhibition in vitro under conditions similar to those of the primase‐pyrophosphatase experiment. The MTT assay also confirmed the inhibitors' anti‐leishmanial properties. Parasite growth and morphological analysis were performed by culturing cells in the presence of inhibitors. Biochemical characterization revealed that LdPriS activity was unstable, but was highly stabilized upon association with LdPriL in LdPri . LdPri was found to be thermostable and possesses 3′‐terminal nucleotidyltransferase activity. Additionally, in silico and in vitro studies evaluated Pritelivir (BAY 57‐1293) as the most efficient LdPri complex inhibitor, followed by Epigallocatechin Gallate (EGCG). Moreover, kinetic studies showed that Pritelivir and EGCG exhibit competitive and uncompetitive inhibition, respectively, for both NTP and DNA substrates. Pritelivir effectively disrupted the L. donovani cell cycle, and the replication mechanism in treated promastigotes showed irregular shapes and short flagella.
- 1 August 2021
- Published by Elsevier in Immunology Letters
- Vol. 236, 31-36
Dengue virus induces interferon-β by activating RNA sensing pathways in megakaryocytes
- 1 August 2021
- Published by Elsevier in Immunology Letters
- Vol. 236, 31-36
Dengue virus induces interferon-β by activating RNA sensing pathways in megakaryocytes
- 1 October 2019
- Published by Elsevier in Human Immunology
- Vol. 80 (10) , 855-862
Phenotypic analysis of monocytes and CD4+ T cells in hepatitis E patients with or without pregnancy
- 1 October 2019
- Published by Elsevier in Human Immunology
- Vol. 80 (10) , 855-862
Phenotypic analysis of monocytes and CD4+ T cells in hepatitis E patients with or without pregnancy
- 16 August 2018
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 25 (12) , 1617-1623
Association of Toll‐like receptor 4 polymorphism with hepatitis E virus‐infected Indian patients
Summary: Hepatitis E infection caused by hepatitis E virus (HEV), a major public health concern in developing countries, is responsible for sporadic and epidemic acute viral hepatitis in adults. Pathogenesis of hepatitis E infection is poorly understood. Toll‐like receptors (TLRs) are the key players of innate immunity recognize pathogen‐associated molecular patterns (PAMPs). Previously, we found higher TLR4 expression (at protein and gene level) with impaired cytokine response upon stimulus of PBMCs with LPS in HEV‐infected patients. In view of the earlier observations of the association of polymorphisms in TLR4 genes (A299G, C399T) with liver diseases, we investigated TLR4 polymorphisms in HEV‐infected patients. We observed the significant association of TLR4‐399CC and CT alleles with hepatitis E (both subclinical and acute patients). Carrier frequency of TLR4‐399 CT was lower in patients’ categories in comparison with the controls. Higher frequency of allele TLR4‐399C significantly correlated with disease progression. Acute hepatitis E patients showed the higher frequency of CG and TA haplotypes, while the rare haplotype (TG) was more frequent in controls. The other single nucleotide polymorphism (SNP) at TLR4‐299 (A>G) did not show any difference. We report here for the first time the association of TLR4 polymorphism with hepatitis E and suggest that TLR 4 hyporesponsiveness during HEV infection might be related to its polymorphism.
- 16 August 2018
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 25 (12) , 1617-1623
Association of Toll‐like receptor 4 polymorphism with hepatitis E virus‐infected Indian patients
Summary: Hepatitis E infection caused by hepatitis E virus (HEV), a major public health concern in developing countries, is responsible for sporadic and epidemic acute viral hepatitis in adults. Pathogenesis of hepatitis E infection is poorly understood. Toll‐like receptors (TLRs) are the key players of innate immunity recognize pathogen‐associated molecular patterns (PAMPs). Previously, we found higher TLR4 expression (at protein and gene level) with impaired cytokine response upon stimulus of PBMCs with LPS in HEV‐infected patients. In view of the earlier observations of the association of polymorphisms in TLR4 genes (A299G, C399T) with liver diseases, we investigated TLR4 polymorphisms in HEV‐infected patients. We observed the significant association of TLR4‐399CC and CT alleles with hepatitis E (both subclinical and acute patients). Carrier frequency of TLR4‐399 CT was lower in patients’ categories in comparison with the controls. Higher frequency of allele TLR4‐399C significantly correlated with disease progression. Acute hepatitis E patients showed the higher frequency of CG and TA haplotypes, while the rare haplotype (TG) was more frequent in controls. The other single nucleotide polymorphism (SNP) at TLR4‐299 (A>G) did not show any difference. We report here for the first time the association of TLR4 polymorphism with hepatitis E and suggest that TLR 4 hyporesponsiveness during HEV infection might be related to its polymorphism.
- Open Access
- 17 May 2018
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 12 (5) , e0006439
Mosquito saliva alone has profound effects on the human immune system
Mosquito saliva is a very complex concoction of >100 proteins, many of which have unknown functions. The effects of mosquito saliva proteins injected into our skin during blood feeding have been studied mainly in mouse models of injection or biting, with many of these systems producing results that may not be relevant to human disease. Here, we describe the numerous effects that mosquito bites have on human immune cells in mice engrafted with human hematopoietic stem cells. We used flow cytometry and multiplex cytokine bead array assays, with detailed statistical analyses, to detect small but significant variations in immune cell functions after 4 mosquitoes fed on humanized mice footpads. After preliminary analyses, at different early times after biting, we focused on assessing innate immune and subsequent cellular responses at 6 hours, 24 hours and 7 days after mosquito bites. We detected both Th1 and Th2 human immune responses, and delayed effects on cytokine levels in the blood, and immune cell compositions in the skin and bone marrow, up to 7 days post-bites. These are the first measurements of this kind, with human immune responses in whole animals, bitten by living mosquitoes, versus previous studies using incomplete mouse models and salivary gland extracts or needle injected saliva. The results have major implications for the study of hematophagous insect saliva, its effects on the human immune system, with or without pathogen transmission, and the possibility of determining which of these proteins to target for vaccination, in attempts to block transmission of numerous tropical diseases. Mosquito saliva proteins have numerous effects on the immune system, and we describe here the use of mice with a humanized immune system to study the effects of mosquito bites on human cells. Our results show that the number of immune cell types affected is much larger than previously described, and some immune responses to mosquito bites can be detected up until 7 days post-bite. The biological significance of these changes remains to be determined, but it might explain how some pathogens, such as viruses, can spread through the body in these cells, replicate to higher extents, and even remain in some tissues for far longer than detected in blood.
- 17 May 2018
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 12 (5) , e0006439
Open AccessMosquito saliva alone has profound effects on the human immune system
Mosquito saliva is a very complex concoction of >100 proteins, many of which have unknown functions. The effects of mosquito saliva proteins injected into our skin during blood feeding have been studied mainly in mouse models of injection or biting, with many of these systems producing results that may not be relevant to human disease. Here, we describe the numerous effects that mosquito bites have on human immune cells in mice engrafted with human hematopoietic stem cells. We used flow cytometry and multiplex cytokine bead array assays, with detailed statistical analyses, to detect small but significant variations in immune cell functions after 4 mosquitoes fed on humanized mice footpads. After preliminary analyses, at different early times after biting, we focused on assessing innate immune and subsequent cellular responses at 6 hours, 24 hours and 7 days after mosquito bites. We detected both Th1 and Th2 human immune responses, and delayed effects on cytokine levels in the blood, and immune cell compositions in the skin and bone marrow, up to 7 days post-bites. These are the first measurements of this kind, with human immune responses in whole animals, bitten by living mosquitoes, versus previous studies using incomplete mouse models and salivary gland extracts or needle injected saliva. The results have major implications for the study of hematophagous insect saliva, its effects on the human immune system, with or without pathogen transmission, and the possibility of determining which of these proteins to target for vaccination, in attempts to block transmission of numerous tropical diseases. Mosquito saliva proteins have numerous effects on the immune system, and we describe here the use of mice with a humanized immune system to study the effects of mosquito bites on human cells. Our results show that the number of immune cell types affected is much larger than previously described, and some immune responses to mosquito bites can be detected up until 7 days post-bite. The biological significance of these changes remains to be determined, but it might explain how some pathogens, such as viruses, can spread through the body in these cells, replicate to higher extents, and even remain in some tissues for far longer than detected in blood.
- Open Access
- 24 August 2017
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 217 (4) , 538-547
Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus
While Zika virus (ZIKV) is mainly transmitted by mosquitoes, numerous cases of sexual transmission have been reported during recent outbreaks. Little is known about which host cell types or entry factors aid in mediating this sexual transmission. In this study, we investigated ZIKV cell tropism by infecting 2 types of human prostate cells with 3 contemporary ZIKV isolates from persons infected in the Americas. We used real-time quantitative polymerase chain reaction and immunofluorescence analyses to measure infection and flow cytometry to detect entry factor expression. Here we show that ZIKV infects, replicates, and produces infectious virus in prostate stromal mesenchymal stem cells, epithelial cells, and organoids made with a combination of these cells. We also show that prostate cells express several well-characterized flavivirus attachment factors. In contrast, dengue virus does not infect or does not replicate in these prostate cells, although it is known to use similar receptors. Our results indicate that ZIKV favors infection of stromal cells more so than epithelial cells in organoids, possibly indicating a preference for stem cells in general. Overall, these results suggest that ZIKV replication occurs in the human prostate and can account for ZIKV secretion in semen, thus leading to sexual transmission.
- 24 August 2017
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 217 (4) , 538-547
Open AccessReplication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus
While Zika virus (ZIKV) is mainly transmitted by mosquitoes, numerous cases of sexual transmission have been reported during recent outbreaks. Little is known about which host cell types or entry factors aid in mediating this sexual transmission. In this study, we investigated ZIKV cell tropism by infecting 2 types of human prostate cells with 3 contemporary ZIKV isolates from persons infected in the Americas. We used real-time quantitative polymerase chain reaction and immunofluorescence analyses to measure infection and flow cytometry to detect entry factor expression. Here we show that ZIKV infects, replicates, and produces infectious virus in prostate stromal mesenchymal stem cells, epithelial cells, and organoids made with a combination of these cells. We also show that prostate cells express several well-characterized flavivirus attachment factors. In contrast, dengue virus does not infect or does not replicate in these prostate cells, although it is known to use similar receptors. Our results indicate that ZIKV favors infection of stromal cells more so than epithelial cells in organoids, possibly indicating a preference for stem cells in general. Overall, these results suggest that ZIKV replication occurs in the human prostate and can account for ZIKV secretion in semen, thus leading to sexual transmission.
- 1 May 2017
- Published by Elsevier in Antiviral Research
- Vol. 141, 62-72
Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses
- 1 May 2017
- Published by Elsevier in Antiviral Research
- Vol. 141, 62-72
Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses
- Open Access
- 27 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep41389
Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication
Zika virus (ZIKV) is an emerging mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Although ZIKV has been predominately associated with a mild or asymptomatic dengue-like disease, its appearance in the Americas has been accompanied by a multi-fold increase in reported incidence of fetal microcephaly and brain malformations. The source and mode of vertical transmission from mother to fetus is presumptively transplacental, although a causal link explaining the interval delay between maternal symptoms and observed fetal malformations following infection has been missing. In this study, we show that primary human placental trophoblasts from non-exposed donors (n = 20) can be infected by primary passage ZIKV-FLR isolate, and uniquely allowed for ZIKV viral RNA replication when compared to dengue virus (DENV). Consistent with their being permissive for ZIKV infection, primary trophoblasts expressed multiple putative ZIKV cell entry receptors, and cellular function and differentiation were preserved. These findings suggest that ZIKV-FLR strain can replicate in human placental trophoblasts without host cell destruction, thereby serving as a likely permissive reservoir and portal of fetal transmission with risk of latent microcephaly and malformations.
- 27 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep41389
Open AccessPrimary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication
Zika virus (ZIKV) is an emerging mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Although ZIKV has been predominately associated with a mild or asymptomatic dengue-like disease, its appearance in the Americas has been accompanied by a multi-fold increase in reported incidence of fetal microcephaly and brain malformations. The source and mode of vertical transmission from mother to fetus is presumptively transplacental, although a causal link explaining the interval delay between maternal symptoms and observed fetal malformations following infection has been missing. In this study, we show that primary human placental trophoblasts from non-exposed donors (n = 20) can be infected by primary passage ZIKV-FLR isolate, and uniquely allowed for ZIKV viral RNA replication when compared to dengue virus (DENV). Consistent with their being permissive for ZIKV infection, primary trophoblasts expressed multiple putative ZIKV cell entry receptors, and cellular function and differentiation were preserved. These findings suggest that ZIKV-FLR strain can replicate in human placental trophoblasts without host cell destruction, thereby serving as a likely permissive reservoir and portal of fetal transmission with risk of latent microcephaly and malformations.
- Open Access
- 21 September 2016
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 10 (9) , e0005019
Characterization of a Zika Virus Isolate from Colombia
Zika virus (Flavivirus genus) is the first mosquito-borne virus known to cause high rates of microcephaly and abortion in humans. Typically, Zika virus causes a self-limiting, systemic illness; however, the current outbreak of Zika virus in the Americas has been associated with increased rates of fetal malformations and Guillain-Barré syndrome. Very few Zika virus isolates have been described in the literature, and live viruses are needed to perform studies of pathogenesis and to develop vaccines and treatments. We isolated Zika virus, strain FLR, directly from the serum of an individual infected in Barranquilla, Colombia (December, 2015). Here, we describe the patient’s clinical course and characterize strain FLR by its growth characteristics in mosquito and mammalian cells and its partial resistance to UV-inactivation. The full genome sequence of FLR was also analyzed (including the 3’ un-translated region), to determine its probable geographic origin, and to pinpoint structural differences from other Zika virus strains. We anticipate that the study of this low passage, clinical isolate of Zika virus, which is available for worldwide distribution, will help uncover the mechanisms of viral replication and host immune responses contributing to the varied and sometimes severe clinical presentations seen during the current epidemic in the Americas. Zika virus (ZIKV) is a mosquito-transmitted virus that causes a febrile illness characterized by a pronounced rash and occasional arthralgia. Serious complications from ZIKV infections were rarely reported until 2015, when Brazilian officials first reported an association between ZIKV infections and a dramatic increase in microcephaly and Guillian-Barré syndrome. Since then, ZIKV has been found in 39 countries in the Americas. Thus, the identification and characterization of ZIKV strains from the current outbreak are of utmost importance. In this study, we successfully isolated a ZIKV strain (ZIKV-FLR) from an individual who was bitten by mosquitoes while traveling in an area of Colombia that had ongoing dengue, chikungunya, and ZIKV transmission. Our analysis of the full genome sequence revealed that this virus strain may have originated in the Caribbean and was not directly imported from Brazil. We also discovered that this virus strain was partially resistant to inactivation by ultraviolet irradiation, when compared to dengue virus. Further work is needed to elucidate the underlying mechanisms behind this increased resistance and potential to cause more severe disease.
- 21 September 2016
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 10 (9) , e0005019
Open AccessCharacterization of a Zika Virus Isolate from Colombia
Zika virus (Flavivirus genus) is the first mosquito-borne virus known to cause high rates of microcephaly and abortion in humans. Typically, Zika virus causes a self-limiting, systemic illness; however, the current outbreak of Zika virus in the Americas has been associated with increased rates of fetal malformations and Guillain-Barré syndrome. Very few Zika virus isolates have been described in the literature, and live viruses are needed to perform studies of pathogenesis and to develop vaccines and treatments. We isolated Zika virus, strain FLR, directly from the serum of an individual infected in Barranquilla, Colombia (December, 2015). Here, we describe the patient’s clinical course and characterize strain FLR by its growth characteristics in mosquito and mammalian cells and its partial resistance to UV-inactivation. The full genome sequence of FLR was also analyzed (including the 3’ un-translated region), to determine its probable geographic origin, and to pinpoint structural differences from other Zika virus strains. We anticipate that the study of this low passage, clinical isolate of Zika virus, which is available for worldwide distribution, will help uncover the mechanisms of viral replication and host immune responses contributing to the varied and sometimes severe clinical presentations seen during the current epidemic in the Americas. Zika virus (ZIKV) is a mosquito-transmitted virus that causes a febrile illness characterized by a pronounced rash and occasional arthralgia. Serious complications from ZIKV infections were rarely reported until 2015, when Brazilian officials first reported an association between ZIKV infections and a dramatic increase in microcephaly and Guillian-Barré syndrome. Since then, ZIKV has been found in 39 countries in the Americas. Thus, the identification and characterization of ZIKV strains from the current outbreak are of utmost importance. In this study, we successfully isolated a ZIKV strain (ZIKV-FLR) from an individual who was bitten by mosquitoes while traveling in an area of Colombia that had ongoing dengue, chikungunya, and ZIKV transmission. Our analysis of the full genome sequence revealed that this virus strain may have originated in the Caribbean and was not directly imported from Brazil. We also discovered that this virus strain was partially resistant to inactivation by ultraviolet irradiation, when compared to dengue virus. Further work is needed to elucidate the underlying mechanisms behind this increased resistance and potential to cause more severe disease.
- 1 December 2014
- Published by Elsevier in Human Immunology
- Vol. 75 (12) , 1147-1154
Toll like receptors in self-recovering hepatitis E patients with or without pregnancy
- 1 December 2014
- Published by Elsevier in Human Immunology
- Vol. 75 (12) , 1147-1154
Toll like receptors in self-recovering hepatitis E patients with or without pregnancy